These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8813633)

  • 1. Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions.
    Kristiansen K; Dahl SG
    Eur J Pharmacol; 1996 Jun; 306(1-3):195-210. PubMed ID: 8813633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor.
    Edvardsen O; Sylte I; Dahl SG
    Brain Res Mol Brain Res; 1992 Jul; 14(3):166-78. PubMed ID: 1331649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
    Wurch T; Colpaert FC; Pauwels PJ
    Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
    Nishio H; Inoue A; Nakata Y
    Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
    Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
    Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists.
    Glennon RA; Metwally K; Dukat M; Ismaiel AM; De los Angeles J; Herndon J; Teitler M; Khorana N
    Curr Top Med Chem; 2002 Jun; 2(6):539-58. PubMed ID: 12052193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
    Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner.
    Johnson MP; Wainscott DB; Lucaites VL; Baez M; Nelson DL
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):1-6. PubMed ID: 9387857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
    Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA
    J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist.
    Westkaemper RB; Runyon SP; Bondarev ML; Savage JE; Roth BL; Glennon RA
    Eur J Pharmacol; 1999 Sep; 380(1):R5-7. PubMed ID: 10513561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
    Popova NK; Barykina NN; Alekhina TA; Naumenko KS; Kulikov AV
    Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):857-64. PubMed ID: 10512006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes.
    Zgombick JM; Schechter LE; Kucharewicz SA; Weinshank RL; Branchek TA
    Eur J Pharmacol; 1995 Sep; 291(1):9-15. PubMed ID: 8549648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of similarity matrices and genetic neural networks in quantitative structure-activity relationships of 2- or 4-(4-Methylpiperazino)pyrimidines: 5-HT(2A) receptor antagonists.
    Borowski T; Król M; Broclawik E; Baranowski TC; Strekowski L; Mokrosz MJ
    J Med Chem; 2000 May; 43(10):1901-9. PubMed ID: 10821703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.